388 related articles for article (PubMed ID: 20074669)
1. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
[TBL] [Abstract][Full Text] [Related]
3. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.
Van Beneden K; Coppieters K; Laroy W; De Keyser F; Hoffman IE; Van den Bosch F; Vander Cruyssen B; Drennan M; Jacques P; Rottiers P; Verbruggen G; Contreras R; Callewaert N; Elewaut D
Ann Rheum Dis; 2009 Aug; 68(8):1360-5. PubMed ID: 18772190
[TBL] [Abstract][Full Text] [Related]
4. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
5. Effect of pine pollen extract on experimental chronic arthritis.
Lee KH; Choi EM
Phytother Res; 2009 May; 23(5):651-7. PubMed ID: 19148883
[TBL] [Abstract][Full Text] [Related]
6. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
You X; Pan M; Gao W; Shiah HS; Tao J; Zhang D; Koumpouras F; Wang S; Zhao H; Madri JA; Baker D; Cheng YC; Yin Z
Arthritis Rheum; 2006 Mar; 54(3):877-86. PubMed ID: 16508970
[TBL] [Abstract][Full Text] [Related]
7. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
8. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous injections of a TNF-alpha antagonistic peptide inhibit both inflammation and bone resorption in collagen-induced murine arthritis.
Kojima T; Aoki K; Nonaka K; Saito H; Azuma M; Iwai H; Varghese BJ; Yoshimasu H; Baron R; Ohya K; Amagasa T
J Med Dent Sci; 2005 Mar; 52(1):91-9. PubMed ID: 15868746
[TBL] [Abstract][Full Text] [Related]
11. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library.
Lee SI; Hyun PM; Kim SH; Kim KS; Lee SK; Kim BS; Maeng PJ; Lim JS
Arthritis Rheum; 2005 Jan; 52(1):345-53. PubMed ID: 15641090
[TBL] [Abstract][Full Text] [Related]
14. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
Jin CH; Chae SY; Kim TH; Yang HK; Lee EY; Song YW; Jo DG; Lee KC
J Pharmacol Exp Ther; 2010 Mar; 332(3):858-65. PubMed ID: 19933369
[TBL] [Abstract][Full Text] [Related]
15. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.
Magnusson SE; Andrén M; Nilsson KE; Sondermann P; Jacob U; Kleinau S
Clin Immunol; 2008 May; 127(2):225-33. PubMed ID: 18346938
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
18. Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor.
Mageed RA; Adams G; Woodrow D; Podhajcer OL; Chernajovsky Y
Gene Ther; 1998 Dec; 5(12):1584-92. PubMed ID: 10023437
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
20. CD200-Fc, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis.
Simelyte E; Criado G; Essex D; Uger RA; Feldmann M; Williams RO
Arthritis Rheum; 2008 Apr; 58(4):1038-43. PubMed ID: 18383359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
